Abstract
The purpose of this study is to determine the ocular manifestations of systemic lupus erythematosus and its correlation with the disease activity. Fifty-two lupus patients and 20 healthy controls were included in this study. All patients have undergone complete rheumatological, neurological, and ophthalmic examination including visual acuity, slit-lamp examination of the anterior segment, and dry eye evaluation using Rose Bengal stain and Schirmer test. Fundus examination and fundus photography were done to the suspected cases. Eighteen patients (34.6%) had ocular lesion, from which only 13 (25%) patients were symptomatic. Keratoconjunctivitis was the most common ocular lesion. There was a highly statistically significant difference between patients and controls as regarding all ocular lesions (***P > 0.0001). There was good correlation between disease activity index and presence of ocular lesion. Ocular manifestations are common in SLE patients. Lupus retinopathy may reflect systemic, particularly CNS, vascular damage.
References
Oates J, Levesque M, Hobbs M (2003) Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in African-Americans. J Rheumatol 30(1):60–67
Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stenens MB (1986) Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol 104:558–563
Charles H (1991) Retinal vasculitis. In: Tasman W, Jaeger EA (eds) Duane’s clinical ophthalmology. Lippincott, Philadelphia, pp 1–17
Ushiyama O, Ushiyama K, Koarada S (2000) Retinal disease in patients with systemic lupus erythematosus. Ann Rheumatol Dis 59:705–708
Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GR (1989) Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the ‘primary’ antiphospholipid syndrome. Ann Rheumatol Dis 48:358–361
Arevalo JF, Lowder CY, Muci-Mendoza R (2002) Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol 13(6):404–410
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (Letter). Arthritis Rheum 40:1725
Ladman DD, Ibancz D, Urowitz MB (2000) Systemic lupus erythematosus disease activity index. J Rheumatol 29:288–291
Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M (1988) Lupus retinopathy. Arthr Rheumatol 31:1105–1110
SPSS Inc (2001) Statistical package for social sciences incorporation for windows, version 11
Al-Mayouf SM, Al-Hemidan AI (2003) Ocular manifestations of systemic lupus erythematosus. Saudi Med J 24:964–966
Gilbo IM, Kvien TK, Uhlig T, Husby G (2001) Sicca symptoms and secondary Sjögren’s syndrome in systemic lupus erythematosus. Ann Rheum Dis 60:1103–1109
Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C (2007) Ocular manifestations of systemic lupus erythematosus. Rheumatology 46(12):1757–1762. doi:10.1093/rheumatology/kem173
Russell W (2004) Clinical mini-review; systemic lupus and the eye. Ocul Immunol Inflamm 12:87–99
Nguyen QD, Foster CS (1998) Systemic lupus erythematosus and the eye. Int Ophthalmol Clin 38:33–60
Soo MP, Chow SK, Tan CT, Nadior N (2000) The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms. Lupus 9(7):511–514
Kevin W, Thomas E (1997) The eye and systemic lupus erythematosus. Scand J Rheumatol 26:412–418
Ropes MW (1976) Systemic lupus erythematosus. Harvard University Press, Cambridge
Asherson RA, Cervera R (1997) Antiphospholipid syndrome. In: Kelly WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 5th edn. Saunders, Philadelphia, pp 1057–1064
Harris EN, Gharavi AE, Boey M, Mackworth-Young CG, Loizou S, Hughes GRV (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet ii(8361):1211–1214
Ishii Y, Nagasawa K, Mayumi T, Niho Y (1990) Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus. Ann Rheum Dis 49:387–390
Ushiyama O, Ushiyama K, Koarada S (2000) Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis 59:705–708
Lie JT, Kobayashi S, Tokano Y, Hashimoto H (1995) Systemic and cerebral vasculitis coexisting with disseminated coagulopathy in systemic lupus erythematosus associated with antiphospholipid syndrome. J Rheumatol 22:2173–2217
Benalexander AP, Merchant A, Stephen Foster C (2002) Peripheral ulcerative keratitis in systemic lupus erythematosus. Digit J Ophthalmol
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
EL-Shereef, R.R., Mohamed, A.S. & Hamdy, L. Ocular manifestation of systemic lupus erythematosus. Rheumatol Int 33, 1637–1642 (2013). https://doi.org/10.1007/s00296-011-2296-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2296-x